Contraline
PrivateLast Round
Series B
Jun 2, 2026
Est. Valuation
$53.5M
Total Funding Raised
$113.85M
Momentum Score
25 /100
Company Overview
Contraline is a clinical-stage biotechnology company developing a long-lasting, non-hormonal, and reversible male contraceptive hydrogel.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Contraline Comps
Public and private peers based on sector, stage, and business model.
Contraline Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 2, 2026 | ||||
| Series A Extension | Nov 10, 2022 | ||||
| Series A | Oct 25, 2021 | ||||
| Grant | Nov 18, 2020 | ||||
| Grant | Jan 24, 2019 | ||||
Seed | Apr 18, 2017 |
Key People
Founding team and executive leadership
Contraline Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Male Contraceptive Initiative | Grant |
| RA Capital Management | Series B |
| GV | Series B, Series A Extension |
| Metaplanet Holdings | Series A, Series A Extension |
| Founders Fund | Series A, Seed |
| Invus Opportunities | Series B |
| Virginia Innovation Partnership Corporation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
$93M round led by BVF Partners and RA Capital Management.
- Aug 6, 2025
Exercised exclusive license option for male contraceptive gel NES/T.
Contraline Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Contraline's valuation, stock price, and market status.
